Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam.

Visser M, Deeg DJ, Lips P; Longitudinal Aging Study Amsterdam..

J Clin Endocrinol Metab. 2003 Dec;88(12):5766-72.

PMID:
14671166
2.

Sarcopenia: a potential cause and consequence of type 2 diabetes in Australia's ageing population?

Scott D, de Courten B, Ebeling PR.

Med J Aust. 2016 Oct 3;205(7):329-33. Review.

PMID:
27681976
3.

Adiposity, muscle mass, and muscle strength in relation to functional decline in older persons.

Schaap LA, Koster A, Visser M.

Epidemiol Rev. 2013;35:51-65. doi: 10.1093/epirev/mxs006. Epub 2012 Dec 4. Review.

PMID:
23221972
4.

Sarcopenia: a predictor of mortality and the need for early diagnosis and intervention.

Filippin LI, Teixeira VN, da Silva MP, Miraglia F, da Silva FS.

Aging Clin Exp Res. 2015 Jun;27(3):249-54. doi: 10.1007/s40520-014-0281-4. Epub 2014 Nov 4. Review.

PMID:
25365952
5.

Vitamin D, PTH and the risk of overall and disease-specific mortality: Results of the Longitudinal Aging Study Amsterdam.

El Hilali J, de Koning EJ, van Ballegooijen AJ, Lips P, Sohl E, van Marwijk HW, Visser M, van Schoor NM.

J Steroid Biochem Mol Biol. 2016 Nov;164:386-394. doi: 10.1016/j.jsbmb.2015.12.001. Epub 2015 Dec 8. Review.

PMID:
26678328
6.

Novel insights on nutrient management of sarcopenia in elderly.

Rondanelli M, Faliva M, Monteferrario F, Peroni G, Repaci E, Allieri F, Perna S.

Biomed Res Int. 2015;2015:524948. doi: 10.1155/2015/524948. Epub 2015 Jan 29. Review.

7.

Hypovitaminosis D and frailty: Epiphenomenon or causal?

Wong YY, Flicker L.

Maturitas. 2015 Dec;82(4):328-35. doi: 10.1016/j.maturitas.2015.07.027. Epub 2015 Aug 1. Review.

PMID:
26277256
8.

The endocrine system and sarcopenia: potential therapeutic benefits.

McIntire KL, Hoffman AR.

Curr Aging Sci. 2011 Dec;4(3):298-305. Review.

PMID:
21529322
9.

Associations of sit-up ability with sarcopenia classification measures in Japanese older women.

Abe T, Yaginuma Y, Fujita E, Thiebaud RS, Kawanishi M, Akamine T.

Interv Med Appl Sci. 2016 Dec;8(4):152-157. doi: 10.1556/1646.8.2016.4.7. Review.

10.

Vitamin D hormone: a multitude of actions potentially influencing the physical function decline in older persons.

Cesari M, Incalzi RA, Zamboni V, Pahor M.

Geriatr Gerontol Int. 2011 Apr;11(2):133-42. doi: 10.1111/j.1447-0594.2010.00668.x. Epub 2010 Dec 6. Review.

11.

Vitamin D signaling in myogenesis: potential for treatment of sarcopenia.

Wagatsuma A, Sakuma K.

Biomed Res Int. 2014;2014:121254. doi: 10.1155/2014/121254. Epub 2014 Jun 30. Review.

12.

Differences among skeletal muscle mass indices derived from height-, weight-, and body mass index-adjusted models in assessing sarcopenia.

Kim KM, Jang HC, Lim S.

Korean J Intern Med. 2016 Jul;31(4):643-50. doi: 10.3904/kjim.2016.015. Epub 2016 Jun 22. Review.

13.

Sarcopenia: designing phase IIB trials.

Chumlea WC, Cesari M, Evans WJ, Ferrucci L, Fielding RA, Pahor M, Studenski S, Vellas B; International Working Group on Sarcopenia Task Force Members..

J Nutr Health Aging. 2011 Jun;15(6):450-5.

14.

Sarcopenia and frailty: new challenges for clinical practice.

Dodds R, Sayer AA.

Clin Med (Lond). 2015 Dec;15 Suppl 6:s88-91. doi: 10.7861/clinmedicine.15-6-s88. Review.

PMID:
26634689
15.

Pharmacologic Options for the Treatment of Sarcopenia.

Morley JE.

Calcif Tissue Int. 2016 Apr;98(4):319-33. doi: 10.1007/s00223-015-0022-5. Epub 2015 Jun 23. Review.

PMID:
26100650
16.

Treating sarcopenia in clinical practice: where are we now?

De Spiegeleer A, Petrovic M, Boeckxstaens P, Van Den Noortgate N.

Acta Clin Belg. 2016 Aug;71(4):197-205. doi: 10.1080/17843286.2016.1168064. Epub 2016 Apr 26. Review.

PMID:
27112427
17.

Sarcopenia: age-related skeletal muscle changes from determinants to physical disability.

Di Iorio A, Abate M, Di Renzo D, Russolillo A, Battaglini C, Ripari P, Saggini R, Paganelli R, Abate G.

Int J Immunopathol Pharmacol. 2006 Oct-Dec;19(4):703-19. Review.

PMID:
17166393
18.

Biomarkers in sarcopenia: A multifactorial approach.

Curcio F, Ferro G, Basile C, Liguori I, Parrella P, Pirozzi F, Della-Morte D, Gargiulo G, Testa G, Tocchetti CG, Bonaduce D, Abete P.

Exp Gerontol. 2016 Dec 1;85:1-8. doi: 10.1016/j.exger.2016.09.007. Epub 2016 Sep 12. Review.

PMID:
27633530
19.

Vitamin E in sarcopenia: current evidences on its role in prevention and treatment.

Khor SC, Abdul Karim N, Ngah WZ, Yusof YA, Makpol S.

Oxid Med Cell Longev. 2014;2014:914853. doi: 10.1155/2014/914853. Epub 2014 Jul 6. Review.

20.

Aging of the endocrine system and its potential impact on sarcopenia.

Vitale G, Cesari M, Mari D.

Eur J Intern Med. 2016 Nov;35:10-15. doi: 10.1016/j.ejim.2016.07.017. Epub 2016 Jul 30. Review.

PMID:
27484963

Supplemental Content

Support Center